🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, asserting the companies withheld alleged dangers that the pain reliever posed to pediatric brain development.

This legal action follows thirty days after President Donald Trump advocated an unsubstantiated connection between consuming Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in young ones.

The attorney general is filing suit against J&J, which previously sold the medication, the exclusive pain medication recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "deceived the public by gaining financially from pain and marketing drugs without regard for the dangers."

The manufacturer asserts there is insufficient reliable data linking Tylenol to autism.

"These companies lied for decades, intentionally threatening millions to boost earnings," Paxton, a Republican, said.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its online platform, the company also said it had "continuously evaluated the relevant science and there is no credible data that indicates a verified association between taking acetaminophen and autism."

Organizations representing medical professionals and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address pain and elevated temperature, which can present major wellness concerns if left untreated.

"In multiple decades of studies on the utilization of paracetamol in gestation, zero credible investigations has successfully concluded that the usage of acetaminophen in any period of gestation causes neurodevelopmental disorders in children," the organization commented.

The lawsuit mentions current declarations from the former administration in arguing the medication is potentially dangerous.

In recent weeks, the former president raised alarms from public health officials when he instructed women during pregnancy to "struggle intensely" not to take Tylenol when sick.

Federal regulators then released a statement that medical professionals should think about restricting the use of Tylenol, while also declaring that "a proven link" between the drug and autism in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to initiate "comprehensive study program" that would determine the cause of autism in a matter of months.

But authorities advised that discovering a unique factor of autism - considered by experts to be the consequence of a complex mix of inherited and surrounding conditions - would not be simple.

Autism is a form of enduring cognitive variation and impairment that affects how individuals experience and engage with the surroundings, and is diagnosed using physician assessments.

In his legal document, the attorney general - who supports Trump who is campaigning for the Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "eliminate any commercial messaging" that claims Tylenol is reliable for pregnant women.

The Texas lawsuit echoes the complaints of a group of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in 2022.

Judicial authorities rejected the legal action, saying research from the parents' expert witnesses was not conclusive.